Financial Survey: Hims & Hers Health (NYSE:HIMS) vs. Health Catalyst (NASDAQ:HCAT)

Hims & Hers Health (NYSE:HIMS) and Health Catalyst (NASDAQ:HCAT) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, risk, profitability, earnings and analyst recommendations.

Analyst Ratings

This is a breakdown of recent recommendations for Hims & Hers Health and Health Catalyst, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	2	11	4	0	2.12
Health Catalyst	1	8	4	0	2.23

Hims & Hers Health presently has a consensus target price of $28.70, indicating a potential upside of 9.88%. Health Catalyst has a consensus target price of $2.77, indicating a potential upside of 100.20%. Given Health Catalyst’s stronger consensus rating and higher possible upside, analysts clearly believe Health Catalyst is more favorable than Hims & Hers Health.

Earnings & Valuation

This table compares Hims & Hers Health and Health Catalyst”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hims & Hers Health	$2.35 billion	2.58	$128.37 million	($0.09)	-290.22
Health Catalyst	$302.48 million	0.34	-$177.97 million	($3.72)	-0.37

Hims & Hers Health has higher revenue and earnings than Health Catalyst. Hims & Hers Health is trading at a lower price-to-earnings ratio than Health Catalyst, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

Hims & Hers Health has a beta of 2.43, indicating that its share price is 143% more volatile than the S&P 500. Comparatively, Health Catalyst has a beta of 1.63, indicating that its share price is 63% more volatile than the S&P 500.

Institutional & Insider Ownership

63.5% of Hims & Hers Health shares are held by institutional investors. Comparatively, 85.0% of Health Catalyst shares are held by institutional investors. 11.8% of Hims & Hers Health shares are held by insiders. Comparatively, 2.6% of Health Catalyst shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares Hims & Hers Health and Health Catalyst’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	-0.56%	6.10%	1.52%
Health Catalyst	-87.69%	-3.52%	-1.77%

Summary

Hims & Hers Health beats Health Catalyst on 9 of the 13 factors compared between the two stocks.

About Hims & Hers Health

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

About Health Catalyst

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases. It offers services expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.